Literature DB >> 26069891

Neutrophil infiltration and the distribution of intestinal metaplasia is associated with metachronous gastric cancer following endoscopic submucosal dissection.

Takafumi Sugimoto, Yutaka Yamaji, Kosuke Sakitani, Yoshihiro Isomura, Shuntaro Yoshida, Atsuo Yamada, Yoshihiro Hirata, Keiji Ogura, Makoto Okamoto, Kazuhiko Koike.   

Abstract

BACKGROUND: Endoscopic submucosal dissection (ESD) of early gastric cancer is a minimally invasive procedure. However, the risk for metachronous cancers after successful cancer treatment remains high and the risk factors for metachronous cancers have not been elucidated.
OBJECTIVE: To evaluate the risk factors for metachronous gastric cancers after ESD with a long-term follow-up.
METHODS: A total of 155 consecutive patients (119 men, 36 women, mean age 68.9 years) were treated with ESD between September 2000 and September 2009. Biopsy specimens were obtained from the greater curvature of the antrum and middle corpus to evaluate gastric mucosal status, including Helicobacter pylori, intestinal metaplasia (IM) and neutrophil infiltration (NI) before ESD. Follow-up endoscopy after ESD was scheduled at two and six months, one year and annually thereafter. H pylori eradication was recommended when possible.
RESULTS: The median follow-up period was 4.2 years. Metachronous gastric cancers were found in 23 of 155 patients (3.5% per year). No local recurrences were observed. The cumulative incidence of metachronous gastric cancer was significantly high in IM and NI in the corpus (P=0.0093 and P=0.0025, respectively [log-rank test]). The ORs for IM and NI in the corpus were 2.65 and 3.06, respectively, according to the Cox proportional hazards model (P=0.024 and P=0.0091, respectively).
CONCLUSIONS: The presence of IM and NI in the corpus was closely related to the development of metachronous gastric cancer after ESD.

Entities:  

Mesh:

Year:  2015        PMID: 26069891      PMCID: PMC4578456          DOI: 10.1155/2015/950734

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  36 in total

1.  Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.

Authors:  Yuji Maehata; Shotaro Nakamura; Kiyoshi Fujisawa; Motohiro Esaki; Tomohiko Moriyama; Kouichi Asano; Yuta Fuyuno; Kan Yamaguchi; Issei Egashira; Hyonji Kim; Motonobu Kanda; Minako Hirahashi; Takayuki Matsumoto
Journal:  Gastrointest Endosc       Date:  2011-10-21       Impact factor: 9.427

2.  Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation.

Authors:  Masaaki Kodama; Kazunari Murakami; Tadayoshi Okimoto; Takashi Abe; Yoshifumi Nakagawa; Kazuhiro Mizukami; Masahiro Uchida; Kunimitsu Inoue; Toshio Fujioka
Journal:  Digestion       Date:  2012-01-19       Impact factor: 3.216

Review 3.  Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract.

Authors:  Roy Soetikno; Tonya Kaltenbach; Ronald Yeh; Takuji Gotoda
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

4.  Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis.

Authors:  G D Eslick; L L Lim; J E Byles; H H Xia; N J Talley
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

5.  Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.

Authors:  Kimihiko Yanaoka; Masashi Oka; Hiroshi Ohata; Noriko Yoshimura; Hisanobu Deguchi; Chizu Mukoubayashi; Shotaro Enomoto; Izumi Inoue; Mikitaka Iguchi; Takao Maekita; Kazuki Ueda; Hirotoshi Utsunomiya; Hideyuki Tamai; Mitsuhiro Fujishiro; Masataka Iwane; Tatsuya Takeshita; Osamu Mohara; Masao Ichinose
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

6.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

7.  Long-term follow-up of gastric histology after Helicobacter pylori eradication.

Authors:  G M Forbes; J R Warren; M E Glaser; D J Cullen; B J Marshall; B J Collins
Journal:  J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 4.029

8.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study.

Authors:  H Isomoto; S Shikuwa; N Yamaguchi; E Fukuda; K Ikeda; H Nishiyama; K Ohnita; Y Mizuta; J Shiozawa; S Kohno
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

10.  Basis of decreased risk of gastric cancer in severe atrophic gastritis with eradication of Helicobacter pylori.

Authors:  Akira Tari; Yasuhiko Kitadai; Masaharu Sumii; Atsunori Sasaki; Hiroshi Tani; Sinji Tanaka; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2006-12-07       Impact factor: 3.487

View more
  6 in total

Review 1.  Characteristics and predictors of gastric cancer after Helicobacter pylori eradication.

Authors:  Satoki Shichijo; Yoshihiro Hirata
Journal:  World J Gastroenterol       Date:  2018-05-28       Impact factor: 5.742

2.  Long-term outcomes after endoscopic submucosal dissection for differentiated-type early gastric cancer that fulfilled expanded indication criteria: A prospective cohort study.

Authors:  Satoki Shichijo; Noriya Uedo; Takashi Kanesaka; Takashi Ohta; Kentaro Nakagawa; Yusaku Shimamoto; Masayasu Ohmori; Masamichi Arao; Taro Iwatsubo; Sho Suzuki; Kenshi Matsuno; Hiroyoshi Iwagami; Shuntaro Inoue; Noriko Matsuura; Akira Maekawa; Hiroko Nakahira; Sachiko Yamamoto; Yoji Takeuchi; Koji Higashino; Ryu Ishihara; Keisuke Fukui; Yuri Ito; Hiroyuki Narahara; Shingo Ishiguro; Hiroyasu Iishi
Journal:  J Gastroenterol Hepatol       Date:  2020-08-06       Impact factor: 4.029

Review 3.  Therapeutic strategies for gastric cancer targeting immune cells: Future directions.

Authors:  Yan Zhao; Yuansong Bai; Meili Shen; Yapeng Li
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

4.  Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication.

Authors:  Osamu Toyoshima; Yutaka Yamaji; Shuntaro Yoshida; Shuhei Matsumoto; Hiroharu Yamashita; Takamitsu Kanazawa; Keisuke Hata
Journal:  Surg Endosc       Date:  2016-09-07       Impact factor: 4.584

5.  Metachronous Gastric Cancer: Another Hurdle for Successful Endoscopic Treatment for Early Gastric Cancer?

Authors:  Moon Won Lee; Gwang Ha Kim
Journal:  Gut Liver       Date:  2020-03-15       Impact factor: 4.519

6.  Endoscopy-based Kyoto classification score of gastritis related to pathological topography of neutrophil activity.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Shuntaro Yoshida; Yoshiki Sakaguchi; Yousuke Nakai; Hidenobu Watanabe; Hidekazu Suzuki; Chizu Tanikawa; Koichi Matsuda; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.